https://es.marketscreener.com/cotizacion/accion/DOCMORRIS-AG-36785697/noticia/ZUR-ROSE-GROUP-UBS-reafirma-su-recomendaci-n-de-venta-40667696/?utm_source=telegram&utm_medium=social&utm_campaign=share